PREGNANCY AFTER KIDNEY TRANSPLANTATION: CURRENT APPROACHES TO ALLOGRAFT MONITORING AND MATERNAL OUTCOMES

DIGITAL OBJECT IDENTIFIER (DOI): https://doi.org/10.67620/sai.59d0005
Z. T. Matkarimov1 , Azimova Marguba2 , Abdurahmonova Nigora3 , Elmurodova Nigina4 , D. N. Komilova5
1 State Institution “Republican Specialized Scientific and Practical Medical Center of Surgery named after Academician V. Vakhidov”, Tashkent, Uzbekistan
2 State Institution “Republican Specialized Scientific and Practical Medical Center of Surgery named after Academician V.Vakhidov”
3 State Institution “Republican Specialized Scientific and Practical Medical Center of Surgery named after Academician V.Vakhidov”
4 State Institution “Republican Specialized Scientific and Practical Medical Center of Surgery named after Academician V.Vakhidov”
5 State Institution “Republican Specialized Scientific and Practical Medical Center of Surgery named after Academician V. Vakhidov”, Tashkent, Uzbekistan
ReceivedSep 19, 2026
RevisedOct 04, 2026
PublishedOct 09, 2026

Аннотация

Pregnancy after kidney transplantation is increasingly achievable, but it remains a high-risk condition requiring coordinated nephrological, transplant, and obstetric care. This review summarizes current evidence on maternal outcomes and approaches to kidney allograft monitoring before conception, during pregnancy, and in the postpartum period. Available meta-analyses show high live-birth rates among kidney transplant recipients, while preeclampsia, hypertensive disorders, preterm birth, infection, and acute allograft rejection remain important complications. Favorable outcomes are most strongly associated with stable baseline allograft function, minimal proteinuria, controlled blood pressure, absence of recent rejection, and pregnancy-compatible immunosuppression. Monitoring should include serial assessment of serum creatinine, proteinuria, blood pressure, urinary infection, and calcineurin-inhibitor concentrations, with particular attention to pregnancy-related pharmacokinetic changes in tacrolimus. Because conventional eGFR equations are not well validated in pregnancy, creatinine trends should be interpreted against individual baseline values and the overall clinical context. Deterioration in allograft function requires careful differentiation among preeclampsia, infection, obstruction, drug toxicity, volume depletion, and acute rejection. Postpartum surveillance is also essential because hemodynamic and pharmacokinetic changes may alter allograft function and immunosuppressive exposure. Current evidence suggests that pregnancy does not necessarily worsen long-term allograft survival in appropriately selected women, although standardized monitoring strategies and better validated biomarkers of early allograft injury are still needed.

Ключевые слова

kidney transplantation; pregnancy; kidney allograft function; preeclampsia; immunosuppression; tacrolimus.

Использованная литература

1. Aivazoglou, L., Sass, N., Silva, H. T., Jr., Sato, J. L., Medina-Pestana, J. O., & De Oliveira, L. G. (2011). Pregnancy after renal transplantation: An evaluation of the graft function. European Journal of Obstetrics & Gynecology and Reproductive Biology, 155(2), 129–131. https://doi.org/10.1016/j.ejogrb.2010.11.020 2. Aktürk, S., Çelebi, Z. K., Erdoğmuş, Ş., Kanmaz, A. G., Yüce, T., Şengül, Ş., & Keven, K. (2015). Pregnancy after kidney transplantation: Outcomes, tacrolimus doses, and trough levels. Transplantation Proceedings, 47(5), 1442–1444. https://doi.org/10.1016/j.transproceed.2015.04.041 3. Cabiddu, G., Spotti, D., Gernone, G., Santoro, D., Moroni, G., Gregorini, G., Giacchino, F., Attini, R., Limardo, M., Gammaro, L., Todros, T., Piccoli, G. B., & Kidney and Pregnancy Study Group of the Italian Society of Nephrology. (2018). A best-practice position statement on pregnancy after kidney transplantation: Focusing on the unsolved questions. Journal of Nephrology, 31(5), 665–681. https://doi.org/10.1007/s40620-018-0499-x 4. Deshpande, N. A., James, N. T., Kucirka, L. M., Boyarsky, B. J., Garonzik-Wang, J. M., Montgomery, R. A., & Segev, D. L. (2011). Pregnancy outcomes in kidney transplant recipients: A systematic review and meta-analysis. American Journal of Transplantation, 11(11), 2388–2404. https://doi.org/10.1111/j.1600-6143.2011.03656.x 5. EBPG Expert Group on Renal Transplantation. (2002). European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrology Dialysis Transplantation, 17(Suppl. 4), 50–55. 6. Hebert, M. F., Zheng, S., Hays, K., Shen, D. D., Davis, C. L., Umans, J. G., Miodovnik, M., Thummel, K. E., & Easterling, T. R. (2013). Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation, 95(7), 908–915. https://doi.org/10.1097/TP.0b013e318278d367 7. Kanbay, M., Brinza, C., Ozbek, L., Unlu, S., Abdel-Rahman, S. M., Guldan, M., Aktas, O., Covic, A., Burlacu, A., & Covic, A. (2025). Long-term impact of pregnancy on mortality and graft outcomes in kidney transplant recipients: A systematic review and meta-analysis. International Urology and Nephrology, 57(11), 3773–3786. https://doi.org/10.1007/s11255-025-04572-5 8. Marushak, A., Weber, T., Bock, J., Birkeland, S. A., Hansen, H. E., Klebe, J., Kristoffersen, K., Rasmussen, K., & Olgaard, K. (1986). Pregnancy following kidney transplantation. Acta Obstetricia et Gynecologica Scandinavica, 65(6), 557–559. https://doi.org/10.3109/00016348609158386 9. Mustafa, M. S., Noorani, A., Abdul Rasool, A., Tashrifwala, F. A. A., Jayaram, S., Raja, S., Jawed, F., Siddiq, M. U., Shivappa, S. G., Hameed, I., & Dadana, S. (2024). Pregnancy outcomes in renal transplant recipients: A systematic review and meta-analysis. Women's Health, 20, 17455057241277520. https://doi.org/10.1177/17455057241277520 10. van Buren, M. C., Schellekens, A., Groenhof, T. K. J., van Reekum, F., van de Wetering, J., Paauw, N. D., & Lely, A. T. (2020). Long-term graft survival and graft function following pregnancy in kidney transplant recipients: A systematic review and meta-analysis. Transplantation, 104(8), 1675–1685. https://doi.org/10.1097/TP.0000000000003026 11. Versluis, J., Bourgonje, A. R., Touw, D. J., Meinderts, J. R., Prins, J. R., de Jong, M. F. C., & Mian, P. (2024). Pharmacokinetics of tacrolimus in pregnant solid-organ transplant recipients: A retrospective study. Journal of Clinical Pharmacology, 64(4), 428–436. https://doi.org/10.1002/jcph.2393

Как цитировать

Z. T. Matkarimov, Azimova Marguba, Abdurahmonova Nigora, Elmurodova Nigina, D. N. Komilova (2026). PREGNANCY AFTER KIDNEY TRANSPLANTATION: CURRENT APPROACHES TO ALLOGRAFT MONITORING AND MATERNAL OUTCOMES. Science and Innovation, 5(9), 43-48. https://doi.org/10.67620/sai.59d0005